Oramed to Present at the American Diabetes Association 77th Scientific Sessions

JERUSALEM, June 6, 2017 /PRNewswire/ — Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (https://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that a scientific abstract summarizing the recent Phase IIb study of its orally ingestible insulin capsule, ORMD-0801, will be presented in a poster at the ADA 77th Scientific Sessions on June 9-13, […]

Join our mailing list

Skip to content